Human Empowerment Aging and Disability (HEAD): New Technologies for Neurorehabilitation (HEAD)

February 16, 2018 updated by: Fondazione Don Carlo Gnocchi Onlus
Congenital or acquired neurological disorders could lead to consistent motor and cognitive disabilities. The continuity and persistency of a tailored home rehabilitation protocol after recovery is crucial to prevent disease aggravation or relapses. The integration of a web-based new technology in home rehabilitation programme can constitute a functional low cost resource by offering patients off-line (and on-line) monitoring and by proposing new motivating ways of rehabilitation through high tech tools such as serious games.

Study Overview

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Milano, Italy, 20148
        • Fondazione Don Carlo Gnocchi Onlus
    • LC
      • Lecco, LC, Italy, 23845
        • Ospedale Valduce
    • TO
      • Torino, TO, Italy, 10131
        • Presidio Sanitario S Camillo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age range 18-85
  • Parkinson Disease (PD - mild to moderate) in stable treatment for at least 3 months
  • Multiple Sclerosis (MS) without relapses in the last 3 months (EDSS ≤ 6)
  • post stroke ( ≥ 6 months after the acute event)

Exclusion Criteria:

  • Mini Mental State Examination < 20
  • limited range of motion
  • severe pain
  • severe deficit of visual acuity or auditory perception or communication and severe dysmetry

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: HEAD Rehabilitation
rehabilitation with IT multimedial devices
Active Comparator: Usual care program
usual care program
Usual care at home program according to healthcare professional's advice

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Health-related quality of life assessed on the short-form 12-item Health Survey (SF-12) questionnaire
Time Frame: change from baseline after 4 months and after 7 months
change from baseline after 4 months and after 7 months
Global cognitive state assessed on MONTREAL COGNITIVE ASSESSMENT (MOCA)
Time Frame: change from baseline after 4 months and after 7 months
change from baseline after 4 months and after 7 months
Endurance assessed on two-minute walking test (2MWT)
Time Frame: change from baseline after 4 months and after 7 months
change from baseline after 4 months and after 7 months
Positive and negative affective state assessed on Positive and Negative Affect Scale (PANAS)
Time Frame: change from baseline after 4 months and after 7 months
change from baseline after 4 months and after 7 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Static balance and fall risk assessed on Berg Balance Scale (BBS)
Time Frame: change from baseline after 4 months and after 7 months
change from baseline after 4 months and after 7 months
Finger dexterity assessed on 9-Hole Peg Test (9HPT)
Time Frame: change from baseline after 4 months and after 7 months
change from baseline after 4 months and after 7 months
Unilateral gross manual dexterity assessed on Box and Blocks Test (BBT)
Time Frame: change from baseline after 4 months and after 7 months
change from baseline after 4 months and after 7 months
Walking speed assessed on 10-Meter Walking Test (10MWT)
Time Frame: change from baseline after 4 months and after 7 months
change from baseline after 4 months and after 7 months
Strength in upper and lower extremities assessed on Motricity Index (MI)
Time Frame: change from baseline after 4 months and after 7 months
change from baseline after 4 months and after 7 months
Attention and concentration assessed on Attention and Concentration test
Time Frame: change from baseline after 4 months and after 7 months
change from baseline after 4 months and after 7 months
Memory abilities assessed on Rivermead Behavioural Memory Test - 3 (RBMT3)
Time Frame: change from baseline after 4 months and after 7 months
change from baseline after 4 months and after 7 months
Caregiver Need assessed on Caregiver Need Assessment (CNA) questionnaire
Time Frame: change from baseline after 4 months and after 7 months
change from baseline after 4 months and after 7 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Franco Molteni, MD, Valduce Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2016

Primary Completion (Actual)

August 1, 2017

Study Completion (Actual)

December 1, 2017

Study Registration Dates

First Submitted

January 12, 2017

First Submitted That Met QC Criteria

January 16, 2017

First Posted (Estimate)

January 19, 2017

Study Record Updates

Last Update Posted (Actual)

February 19, 2018

Last Update Submitted That Met QC Criteria

February 16, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FdG_HEAD_01

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nervous System Diseases

Clinical Trials on Multimedial Rehabilitation

Subscribe